Scrutiny of Other Heart Drugs Could Grow After Failed Trial
688076
Because of PfizerÂs failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny Â and delays Â in getting to market.
147168
The approval of a new drug is a long-term opportunity.
243349
This lung cancer drug is not as effective as once hoped.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
749165
New studies shed some light on these controversial heart treatments, but many questions remain. What patients need to know.
761165
Wyeth (nyse: WYE - news - people ) is set to begin the second phase of a Philadelphia trial in which a plaintiff alleges heart valve injury from the use of the diet drug Pondimin, a drug the company once marketed.
519863
The company faces a pivotal clinical trial.
575659
Forest Laboratories Inc. (FRX) on Tuesday said its experimental hypertension drug failed to meet all its goals in an effectiveness study, an outcome that will delay development and may lead to a new trial.
377206
A study of the arthritis drug Celebrex casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.
330242
Doctors are starting a trial to examine whether there is a link between migraines and a heart defect.
55690
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's  and Schering-Plough Corp's  popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
109195
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s withdrawn arthritis pill Vioxx.
101261
Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patientâs cholesterol should be all that matters.
83148
A popular cholesterol-lowering drug failed to help slow the buildup of artery-clogging plaque in a long-awaited study, the companies that market the medication said yesterday, raising questions about whether its use should be limited.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
655214
In "surprising and disappointing" news, its promising new drug fails clinical trials.